Print | Email Page

TGR BioSciences executes patent strategy facilitating successful merger with Sygnis

August 2018

Jones Day developed and executed the patent strategy to support TGR BioSciences Pty Ltd's immunoassay technology in its merger with Sygnis AG.

For additional information about this matter, please contact: Paul L. Sharer

Client(s): TGR BioSciences Pty Ltd
Office(s): Washington